Hubertus Haas, PhD, Mag.rer.nat.

Medical University of Innsbruck, Innsbruck, Austria, Austria

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-2126) ‘SPECIFIC’ First-In-Human Clinical Trial of ⁶⁸Ga-triacetylfusarinine (TAFC) Siderophore PET/CT for Detection of Invasive Aspergillosis
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT